Vifor Fresenius Medical Care Renal Pharma Ltd., 10% Owner at ChemoCentryx, Inc. (CCXI), sold 259,396 shares at $56.19 ($14.2M) on 2020-07-23, disclosed to the SEC on 2020-07-24.
Open-market sale of $14.2M CCXI by 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $55.45 | 49,028 | $2.7M | 19.2% |
| 2 | $55.45 | 49,028 | $2.7M | 19.2% |
| 3 | $55.85 | 23,441 | $1.3M | 9.2% |
| 4 | $55.85 | 23,441 | $1.3M | 9.2% |
| 5 | $53.54 | 22,148 | $1.2M | 8.4% |
| 6 | $53.54 | 22,148 |
| $1.2M |
| 8.4% |
| 7 | $54.50 | 5,452 | $297K | 2.1% |
| 8 | $55.78 | 6,055 | $338K | 2.4% |
| 9 | $55.78 | 6,055 | $338K | 2.4% |
| 10 | $56.19 | 900 | $51K | 0.4% |
| 11 | $52.31 | 15,689 | $821K | 5.8% |
| 12 | $52.31 | 15,689 | $821K | 5.8% |
| 13 | $52.86 | 9,961 | $527K | 3.7% |
| 14 | $52.86 | 9,961 | $527K | 3.7% |
| 15 | $53.58 | 400 | $21K | 0.2% |
| Total | $54.61 avg | 259,396 | $14.2M | 100% |
| Filing → |
| CCXI | SELL | 2020-07-13 | $28.5M | — | Filing → |